高密度区评分预测大血管闭塞卒中血管内治疗后结局
本研究回顾性纳入542例大血管闭塞卒中血管内治疗后复查CT见高密度区的患者,基于ASPECTS分区并纳入蛛网膜下腔及脑室构建HDA评分。结果显示HDA评分与不良临床结局显著相关,纳入HDA指标后不良结局预测AUC由0.743提升至0.802。
要点
- HDA位于豆状核或脑室时提示出血转化风险增加。
- HDA评分无需专用软件,可用于血管内治疗后风险分层。
- HDA累及豆状核、M1区或蛛网膜下腔提示预后不良。
核心结论
- HDA评分反映术后CT高密度区累及区域数量,与不良临床结局显著相关并可有效预测预后。
- 将HDA指标纳入预测模型后,不良临床结局的AUC从0.743显著提升至0.802(DeLong检验,p<0.01)。
研究设计与样本
- 回顾性、多中心研究。
- 连续纳入1130例接受血管内治疗的大血管闭塞患者,其中542例(326例男性,中位年龄70岁)复查CT见HDA并最终纳入。
- 基于ASPECTS分区,加入蛛网膜下腔和脑室,构建HDA评分。
关键影像表现/征象
- 豆状核区HDA(OR为1.6,95%CI为1.1~2.5,p=0.03)与出血转化相关。
- 脑室内HDA(OR为4.4,95%CI为1.2~16.6,p=0.03)与出血转化相关。
- 豆状核(OR为2.3,95%CI为1.4~3.8,p<0.001)、M1区(OR为3.9,95%CI为1.7~8.9,p=0.001)及蛛网膜下腔(OR为2.1,95%CI为1.2~3.8,p=0.02)HDA与不良临床结局相关。
诊断标准与关键数值
- HDA评分与不良临床结局相关,OR为1.35,95%CI为1.19~1.54,p<0.01。
- HDA评分以累及区域数量计,无需专用软件即可获得。
临床应用与阅片要点
- 血管内治疗后复查CT发现HDA位于豆状核或脑室时需警惕出血转化。
- HDA累及豆状核、M1区或蛛网膜下腔时应提示预后不良风险。
- 可用HDA评分对血管内治疗后患者进行简单量化风险分层。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: High-density areas (HDAs) are frequently observed in follow-up CT of large-vessel occlusions after endovascular therapy. Utilizing the established ASPECTS regions, incorporating the subarachnoid space and ventricles, we developed a novel HDA score to evaluate its correlation and predictive value for hemorrhagic transformations and clinical outcomes.
MATERIALS AND METHODS: This retrospective, multicenter study included consecutive patients who had HDA on follow-up CT after endovascular therapy. Multivariable logistic regression and area under the receiver operating characteristic curve (AUC) analyses assessed the associations and predictive value of HDA location and score with hemorrhagic transformations and unfavorable clinical outcomes.
RESULTS: Among the 1130 consecutive patients treated with endovascular therapy, 542 patients (326 males; median age 70 years) had HDA were finally included. Multivariable logistic regression showed that HDA location in the lentiform nucleus (OR, 1.6; 95% CI: 1.1-2.5; p = 0.03) and ventricles (OR, 4.4; 95% CI: 1.2-16.6; p = 0.03) was associated with hemorrhagic transformations, whereas location in the lentiform nucleus (OR, 2.3; 95% CI: 1.4-3.8; p < 0.001), M1(OR, 3.9; 95% CI: 1.7-8.9; p = 0.001), and subarachnoid space (OR, 2.1; 95% CI: 1.2-3.8; p = 0.02) was associated with unfavorable clinical outcomes, as was the HDA score (OR = 1.35, 95% CI:1.19-1.54, p < 0.01). Including HDA indicators in the model significantly improved its unfavorable clinical outcome predictive power (AUC increased from 0.743 to 0.802; DeLong test; p < 0.01).
CONCLUSION: The HDA score, which reflects the number of HDA involved regions, significantly correlated with unfavorable clinical outcomes and effectively predicted the prognosis.
KEY POINTS: QuestionThe relationship between the location and extent of HDA on postoperative CT and hemorrhagic transformation and clinical outcomes in patients undergoing endovascular therapy is unclear. FindingsHemorrhagic transformation and unfavorable clinical outcomes were independently associated with the specific location of HDAs, and HDA score effectively predicted the prognosis. Clinical relevanceThe HDA score provided a simple quantitative measure that did not require specialized software. It significantly improved the prediction of unfavorable clinical outcomes and provided a risk stratification tool for patients after endovascular therapy.
引用
- Cheng, Shen, Wen, et al. Role of high-density area score in predicting outcomes of large-vessel occlusion stroke after endovascular treatment. Eur Radiol. 2026. PMID: 41528474. doi:10.1007/s00330-025-12259-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。